Number of the records: 1  

Structure-based design and modular synthesis of novel PI4K class II inhibitors bearing a 4-aminoquinazoline scaffold

  1. 1.
    0562658 - ÚOCHB 2023 RIV GB eng J - Journal Article
    Misehe, Mbilo - Klíma, Martin - Matoušová, Marika - Chalupská, Dominika - Dejmek, Milan - Šála, Michal - Mertlíková-Kaiserová, Helena - Bouřa, Evžen - Nencka, Radim
    Structure-based design and modular synthesis of novel PI4K class II inhibitors bearing a 4-aminoquinazoline scaffold.
    Bioorganic and Medicinal Chemistry Letters. Roč. 76, November (2022), č. článku 129010. ISSN 0960-894X. E-ISSN 1464-3405
    R&D Projects: GA MŠMT(CZ) EF16_019/0000729; GA MZd(CZ) NU20-05-00472
    Institutional support: RVO:61388963
    Keywords : phosphatidylinositol 4-kinase class II * PI4K2A inhibitor * quinazoline derivative * SAR investigation * ATP-binding site
    OECD category: Biochemistry and molecular biology
    Impact factor: 2.7, year: 2022
    Method of publishing: Limited access
    https://doi.org/10.1016/j.bmcl.2022.129010

    Novel 4-aminoquinazoline-6-carboxamide derivatives bearing differently substituted aryl or heteroaryl groups at position 7 in the core were rationally designed, synthesized and evaluated for biological activity in vitro as phosphatidylinositol 4-kinase IIα (PI4K2A) inhibitors. The straightforward approach described here enabled the sequential, modular synthesis and broad functionalization of the scaffold in a mere six steps. The SAR investigation reported here is based on detailed structural analysis of the conserved binding mode of ATP and other adenine derivatives to the catalytic site of type II PI4Ks, combined with extensive docking studies. Several compounds exhibited significant activity against PI4K2A. Moreover, we solved a crystal structure of PI4K2B in complex with one of our lead ligand candidates, which validated the ligand binding site and pose predicted by our docking-based ligand model. These discoveries suggest that our structure-based approach may be further developed and employed to synthesize new inhibitors with optimized potency and selectivity for this class of PI4Ks.
    Permanent Link: https://hdl.handle.net/11104/0334914


    Research data: PDB
     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.